Skip to main content

Table 4 Univariate analysis of baseline characteristics and mortality

From: The impact of albumin infusion on the risk of rebleeding and in-hospital mortality in cirrhotic patients admitted for acute gastrointestinal bleeding: a retrospective study of a single institute

 

No death

(n = 1422)

Death

(n = 81)

P value

Age

53.0 ± 13.0

54.2 ± 13.5

0.444

Gender (M)

947 (66.6)

58 (71.6)

0.418

Child-Pugh classification

  

< 0.001

 A

469 (33.0)

5 (6.2)

 

 B

689 (48.5)

26 (32.1)

 

 C

264 (18.6)

50 (61.7)

 

Hepatic encephalopathy

94 (6.6)

29 (35.8)

< 0.001

Ascites

738 (51.9)

12 (14.8)

< 0.001

Rebleeding

79 (5.6)

67 (82.7)

< 0.001

Sources of bleeding

 Varies lesion

1215 (85.4)

60 (74.1)

0.009

 Non-varices lesion

99 (7.0)

1 (1.2)

0.075

 Lower gastrointestinal lesion

45 (3.2)

2 (2.5)

0.983

 Unidentified lesion

109 (7.7)

19 (23.5)

< 0.001

Bilirubin (umol /L) a

31.8 ± 39.0

74.1 ± 116.7

< 0.001

Albumin (g/L) a

30.9 ± 6.1

26.6 ± 6.5

< 0.001

Creatine (mol/L) a

79.7 ± 58.4

114.0 ± 80.0

< 0.001

Hemoglobin (g/L) a

75.7 ± 22.8

74.6 ± 24.0

0.683

Prothrombin time (s) a

16.5 ± 9.5

21.0 ± 13.4

< 0.001

Balloon tamponade

133 (9.4)

36 (44.4)

< 0.001

Endoscopic treatment

507 (35.7)

4 (4.9)

< 0.001

Radiological intervention

381 (26.8)

1 (1.2)

< 0.001

  1. avalues were obtained at admission